MASS
Neutral signalScored 2026-10-12 Drivers: trend, fundamentals. Insiders: neutral. Moteurs : tendance, fondamentaux. Initiés : neutre.
Research, not advice.
À propos
908 Devices Inc.
- Nom
- 908 Devices Inc.
- Secteur
- Healthcare
- Industrie
- Medical - Specialties
- Bourse
- NASDAQ
- Capitalisation
- $474.9M
- Employés
- 172
- PDG
- Kevin J. Knopp
- Site web
- https://www.908devices.com
- Marché
- AQGEN
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 60 000 titres (~674 100,00 $ US)
- Insiders
- Brown Christopher D.
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$2,098,022
Avg sell (VWAP, 90d window) $10.35 vs last close $11.26 (+8.8%)
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
$2,098,022 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.
- Last activity
- 2026-10-07
- Liquidity
- Thin $4,269,142/day · 20d vol
- Last synced
-
2026-10-17 09:40:36
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-10-07 | Brown Christopher D. | Sell · S · 10b5-1 | 30,000 | $11.89 | $356,700 | Form 4 |
| 2026-10-06 | Griffith Joseph H. IV | Sell · S · 10b5-1 | 5,000 | $13.03 | $65,150 | Form 4 |
| 2026-09-17 | Kenneweg John | Sell · S · 10b5-1 | 5,257 | $10.22 | $53,727 | Form 4 |
| 2026-09-16 | Kenneweg John | Sell · S · 10b5-1 | 21,399 | $10.11 | $216,344 | Form 4 |
| 2026-09-15 | Kenneweg John | Sell · S · 10b5-1 | 1,000 | $10.00 | $10,000 | Form 4 |
| 2026-09-02 | Brown Christopher D. | Sell · S · 10b5-1 | 30,000 | $10.58 | $317,400 | Form 4 |
| 2026-08-25 | Griffith Joseph H. IV | Sell · S · 10b5-1 | 11,459 | $10.95 | $125,476 | Form 4 |
| 2026-08-17 | Knopp Kevin J. | Sell · S · 10b5-1 | 20,000 | $10.35 | $207,000 | Form 4 |
| 2026-08-13 | Knopp Kevin J. | Sell · S · 10b5-1 | 7,622 | $10.06 | $76,677 | Form 4 |
| 2026-08-12 | Knopp Kevin J. | Sell · S · 10b5-1 | 2,747 | $10.07 | $27,662 | Form 4 |
| 2026-08-11 | Brown Christopher D. | Sell · S · 10b5-1 | 8,358 | $9.23 | $77,144 | Form 4 |
| 2026-08-11 | Knopp Kevin J. | Sell · S · 10b5-1 | 30,170 | $10.16 | $306,527 | Form 4 |
| 2026-08-10 | Brown Christopher D. | Sell · S · 10b5-1 | 9,442 | $9.03 | $85,261 | Form 4 |
| 2026-08-10 | Knopp Kevin J. | Sell · S · 10b5-1 | 348 | $9.06 | $3,153 | Form 4 |
| 2026-08-05 | Brown Christopher D. | Sell · S · 10b5-1 | 20,000 | $8.49 | $169,800 | Form 4 |
Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Neutral signalScored 2026-10-12 Drivers: trend, fundamentals. Insiders: neutral. Moteurs : tendance, fondamentaux. Initiés : neutre.
MASS presents a deeply unfavorable risk/reward profile: a weak catalyst score of 15 with no identifiable event-driven trigger is compounded by deteriorating fundamentals marked by persistent negative operating margins…
The first sentence of the analysis written for MASS on 2026-10-12 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Unavailable or mixed. – Insider: neutral. All sales (≈ $2.1M) were pre-planned Rule 10b5-1 trades, excluded from the score. No open-market buys or discretionary sales. – Initiés : neutre. Toutes les ventes (≈ $2.1M) sont sous plan 10b5-1 préétabli, exclues du score. Aucun achat ni vente discrétionnaire.
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Supports a bullish reading. Interesting trend — weekly bias up
- Financial indicators Unavailable or mixed. Current ratio 4.24 · operating margin -43% — readings disagree
Suggested stop 10.82, nearest stored support minus 0.5 ATR(3.9% under the last close). Reward/risk to the next stored resistance is 0.77. Wait — that reward/risk is under 2. Research, not advice. Not an order.
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 47.7% | 50.2% | 50.4% | 55.5% | 55.0% | |
| Ebit Margin | -59.3% | -81.4% | -84.9% | -71.4% | -51.4% | |
| Ebitda Margin | -51.4% | -73.6% | -80.2% | -67.9% | -49.2% | |
| Operating Profit Margin | -43.0% | -128.7% | -85.1% | -75.5% | -52.3% | |
| Pretax Profit Margin | -59.3% | -121.6% | -72.9% | -71.6% | -52.5% | |
| Continuous Operations Profit Margin | -59.2% | -121.1% | -72.5% | -71.6% | -52.5% | |
| Net Profit Margin | -65.2% | -121.1% | -72.5% | -71.6% | -52.5% | |
| Bottom Line Profit Margin | -65.2% | -121.1% | -72.5% | -71.6% | -52.5% | |
| Current Ratio | 4.244 | 4.098 | 7.707 | 11.215 | 17.046 | |
| Quick Ratio | 3.862 | 3.455 | 7.045 | 10.564 | 16.512 | |
| Solvency Ratio | -0.694 | -1.504 | -0.907 | -0.615 | -0.459 | |
| Cash Ratio | 3.316 | 1.751 | 5.368 | 9.800 | 15.103 | |
| Price To Earnings Ratio | -5.198 | -1.038 | -9.929 | -7.121 | -32.747 | |
| Price To Earnings Growth Ratio | 0.099 | -0.012 | -1.771 | -0.201 | 0.493 | |
| Forward Price To Earnings Growth Ratio | 0.099 | -0.012 | -1.771 | -0.201 | 0.493 | |
| Price To Earnings Diluted Ratio | -5.585 | -1.038 | -9.929 | -7.121 | -32.747 | |
| Price To Earnings Diluted Growth Ratio | 0.100 | -0.012 | -1.771 | -0.201 | 0.493 | |
| Price To Book Ratio | 1.323 | 0.654 | 2.184 | 1.259 | 3.370 | |
| Price To Sales Ratio | 3.383 | 1.257 | 7.195 | 5.122 | 17.137 | |
| Price To Free Cash Flow Ratio | -7.716 | -2.430 | -13.334 | -10.445 | -24.255 | |
| Price To Operating Cash Flow Ratio | -8.027 | -2.479 | -14.422 | -11.466 | -24.870 | |
| Debt To Assets Ratio | 0.088 | 0.041 | 0.029 | 0.080 | 0.080 | |
| Debt To Equity Ratio | 0.116 | 0.058 | 0.036 | 0.102 | 0.097 | |
| Debt To Capital Ratio | 0.104 | 0.055 | 0.035 | 0.093 | 0.089 | |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 | 0.073 | 0.065 | |
| Financial Leverage Ratio | 1.323 | 1.392 | 1.227 | 1.273 | 1.216 | |
| Working Capital Turnover Ratio | 0.597 | 0.520 | 0.289 | 0.216 | 0.212 | |
| Operating Cash Flow Ratio | -0.695 | -1.203 | -1.111 | -1.089 | -1.960 | |
| Operating Cash Flow Sales Ratio | -0.422 | -0.507 | -0.499 | -0.447 | -0.689 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.040 | 1.020 | 1.082 | 1.098 | 1.025 | |
| Debt Service Coverage Ratio | -1.725 | -23.379 | -18.068 | -246.667 | -42.712 | |
| Interest Coverage Ratio | 0.000 | 0.000 | -212.726 | -274.279 | -45.409 | |
| Short Term Operating Cash Flow Coverage Ratio | -1.418 | -16.218 | -12.430 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | -1.418 | -4.578 | -4.215 | -1.073 | -1.395 | |
| Capital Expenditure Coverage Ratio | -24.804 | -50.244 | -12.254 | -10.235 | -39.460 | |
| Dividend Paid And Capex Coverage Ratio | -24.804 | -50.244 | -12.254 | -10.235 | -39.460 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -3.251 | -0.856 | -6.117 | -2.233 | -25.053 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 47.7% | ▼-2.5% | ▼-4.1% |
| Ebit Margin | -59.3% | ▲22.1% | ▲10.3% |
| Ebitda Margin | -51.4% | ▲22.2% | ▲13.1% |
| Operating Profit Margin | -43.0% | ▲85.6% | ▲33.9% |
| Pretax Profit Margin | -59.3% | ▲62.2% | ▲16.3% |
| Continuous Operations Profit Margin | -59.2% | ▲61.9% | ▲16.2% |
| Net Profit Margin | -65.2% | ▲55.9% | ▲11.4% |
| Bottom Line Profit Margin | -65.2% | ▲55.9% | ▲11.4% |
| Current Ratio | 4.244 | ▲0.146 | ▼-4.618 |
| Quick Ratio | 3.862 | ▲0.408 | ▼-4.425 |
| Solvency Ratio | -0.694 | ▲0.811 | ▲0.142 |
| Cash Ratio | 3.316 | ▲1.566 | ▼-3.751 |
| Price To Earnings Ratio | -5.198 | ▼-4.160 | ▲6.009 |
| Price To Earnings Growth Ratio | 0.099 | ▲0.111 | ▲0.378 |
| Forward Price To Earnings Growth Ratio | 0.099 | ▲0.111 | ▲0.378 |
| Price To Earnings Diluted Ratio | -5.585 | ▼-4.547 | ▲5.699 |
| Price To Earnings Diluted Growth Ratio | 0.100 | ▲0.112 | ▲0.378 |
| Price To Book Ratio | 1.323 | ▲0.669 | ▼-0.435 |
| Price To Sales Ratio | 3.384 | ▲2.126 | ▼-3.435 |
| Price To Free Cash Flow Ratio | -7.716 | ▼-5.286 | ▲3.920 |
| Price To Operating Cash Flow Ratio | -8.027 | ▼-5.548 | ▲4.226 |
| Debt To Assets Ratio | 0.088 | ▲0.046 | ▲0.024 |
| Debt To Equity Ratio | 0.116 | ▲0.059 | ▲0.034 |
| Debt To Capital Ratio | 0.104 | ▲0.050 | ▲0.029 |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | ▼-0.028 |
| Financial Leverage Ratio | 1.323 | ▼-0.069 | ▲0.037 |
| Working Capital Turnover Ratio | 0.597 | ▲0.076 | ▲0.230 |
| Operating Cash Flow Ratio | -0.695 | ▲0.507 | ▲0.516 |
| Operating Cash Flow Sales Ratio | -0.421 | ▲0.086 | ▲0.091 |
| Free Cash Flow Operating Cash Flow Ratio | 1.040 | ▲0.020 | ▼-0.013 |
| Debt Service Coverage Ratio | -1.725 | ▲21.654 | ▲64.785 |
| Interest Coverage Ratio | 0.000 | 0.000 | ▲106.483 |
| Short Term Operating Cash Flow Coverage Ratio | -1.418 | ▲14.800 | ▲4.595 |
| Operating Cash Flow Coverage Ratio | -1.418 | ▲3.160 | ▲1.118 |
| Capital Expenditure Coverage Ratio | -24.804 | ▲25.440 | ▲2.595 |
| Dividend Paid And Capex Coverage Ratio | -24.804 | ▲25.440 | ▲2.595 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -3.251 | ▼-2.395 | ▲4.251 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $190.1M | $75.0M | $361.4M | $240.0M | $723.3M | |
| Enterprise value | $93.9M | $37.5M | $246.3M | $71.1M | $520.0M | |
| EV / Sales | 1.67x | 0.63x | 4.90x | 1.52x | 12.32x | |
| EV / Op. cash flow | -3.96x | -1.24x | -9.83x | -3.40x | -17.88x | |
| EV / Free cash flow | -3.81x | -1.22x | -9.09x | -3.09x | -17.44x | |
| EV / EBITDA | -3.25x | -0.86x | -6.12x | -2.23x | -25.05x | |
| Net debt / EBITDA | 3.33x | 0.85x | 2.86x | 5.31x | 9.79x | |
| Current ratio | 4.24x | 4.10x | 7.71x | 11.21x | 17.05x | |
| Income quality | -1.22x | 0.42x | 0.69x | 0.62x | 1.31x | |
| Graham net-net | $2 | $1 | $4 | $5 | $7 | |
| Tax burden | 109.9% | 99.6% | 99.4% | 100.0% | 100.0% | |
| Interest burden | 100.0% | 149.3% | 85.8% | 100.4% | 102.2% | |
| Working capital | $110.5M | $77.9M | $151.2M | $196.4M | $238.1M | |
| Invested capital | $155.5M | $133.5M | $179.0M | $222.0M | $244.8M | |
| Return on assets | -19.3% | -45.3% | -17.9% | -13.8% | -8.5% | |
| Operating ROA | -13.8% | -42.3% | -19.2% | -14.1% | -10.0% | |
| Return on tangible assets | -23.8% | -63.2% | -19.7% | -15.0% | -8.5% | |
| Return on equity | -25.5% | -63.0% | -22.0% | -17.6% | -10.3% | |
| Return on invested capital | -14.0% | -56.1% | -23.3% | -15.7% | -8.9% | |
| Return on capital employed | -15.5% | -57.1% | -23.7% | -15.8% | -9.0% | |
| Earnings yield | -19.3% | -96.3% | -10.1% | -14.0% | -3.1% | |
| Free cash flow yield | -13.0% | -41.1% | -7.5% | -9.6% | -4.1% | |
| Capex / Op. cash flow | -4.0% | -2.0% | -8.2% | -9.8% | -2.5% | |
| Capex / Depreciation | 21.4% | 12.9% | 85.8% | 126.7% | 79.7% | |
| Capex / Sales | 1.7% | 1.0% | 4.1% | 4.4% | 1.7% | |
| SG&A / Sales | 66.2% | 0.0% | 0.0% | 93.7% | 76.4% | |
| R&D / Sales | 24.6% | 42.8% | 43.6% | 37.4% | 31.0% | |
| Stock comp / Sales | 17.5% | 19.7% | 19.5% | 15.4% | 5.9% | |
| Intangibles / Total assets | 19.2% | 28.4% | 9.0% | 7.6% | 0.0% | |
| Days sales outstanding | 74d | 77d | 65d | 78d | 143d | |
| Days payables outstanding | 105d | 25d | 17d | 24d | 26d | |
| Operating cycle | 235d | 276d | 284d | 297d | 296d | |
| Cash conversion cycle | 130d | 251d | 267d | 273d | 269d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-10-06 908 Devices (NASDAQ:MASS) Hits New 52-Week High – Here’s What Happened 908 Devices Inc. (NASDAQ: MASS - Get Free Report)''s share price hit a new 52-week high during trading on Tuesday. The company traded as high as $13.30 and last traded at $12.8250, with a volume of 39458 shares trading hands. The stock had previously closed at $12.80. Wall Street Analyst Weigh In Several brokerages have issued
- 2026-09-29 Masivo Silver Reports Broad Polymetallic Mineralization from Initial 2026 Drilling Program at Cerro Colorado Project, Sonora, Mexico Vancouver, British Columbia--(Newsfile Corp. - September 29, 2026) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) ("Masivo" or the "Company") is pleased to report encouraging analytical results from Drill Hole CC-26-001, the first drill hole completed as part of the Company''s current exploration program at its Cerro Colorado Project in Sonora, Mexico. CC-26-001 intersected a broad polymetallic mineralized system, including 32.50 metres from 226.30 to 258.80 metres averaging 0.271% Zn, 7.0 g/t Ag, 0.141% Pb, 0.025% Cu and 0.01 g/t Au.
- 2026-09-21 Financial Analysis: IPG Photonics (NASDAQ:IPGP) vs. 908 Devices (NASDAQ:MASS) IPG Photonics (NASDAQ: IPGP - Get Free Report) and 908 Devices (NASDAQ: MASS - Get Free Report) are both technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Profitability This table compares IPG Photonics and 908
- 2026-09-20 908 Devices (NASDAQ:MASS) SVP Sells $53,726.54 in Stock 908 Devices Inc. (NASDAQ: MASS - Get Free Report) SVP John Kenneweg sold 5,257 shares of the business''s stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $10.22, for a total transaction of $53,726.54. Following the sale, the senior vice president owned 57,784 shares of the
- 2026-09-20 Insider Selling: 908 Devices (NASDAQ:MASS) SVP Sells $216,343.89 in Stock 908 Devices Inc. (NASDAQ: MASS - Get Free Report) SVP John Kenneweg sold 21,399 shares of 908 Devices stock in a transaction on Wednesday, September 16th. The shares were sold at an average price of $10.11, for a total transaction of $216,343.89. Following the completion of the sale, the senior vice president directly owned 57,784 shares
- 2026-09-12 Comparing 908 Devices (NASDAQ:MASS) & Plexus (NASDAQ:PLXS) Plexus (NASDAQ: PLXS - Get Free Report) and 908 Devices (NASDAQ: MASS - Get Free Report) are both technology companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, risk and earnings. Analyst Ratings This is a breakdown of current ratings
- 2026-09-04 BlackRock Inc. Takes $16.91 Million Position in 908 Devices Inc. $MASS BlackRock Inc. acquired a new stake in shares of 908 Devices Inc. (NASDAQ: MASS) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 1,944,236 shares of the company''s stock, valued at approximately $16,915,000. BlackRock Inc. owned approximately 5.14% of
- 2026-09-01 908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming 32nd Annual Gabelli Aerospace & Defense Symposium on September 10, 2026, in New York City.908 Devices'' management is scheduled to present at 3:45 p.m. Eastern Time. The presentation is webcast and interested parties can register for th.
- 2026-08-31 908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates 908 Devices (NASDAQ: MASS) outlined its strategy to expand in handheld chemical detection following second-quarter 2026 results that showed revenue growth, a narrower adjusted EBITDA loss and increasing recurring revenue. Speaking at the Midwest IDEAS Conference, CEO and Co-Founder Kevin Knopp said the company has spent the past 18 months reshaping its operations around portable tools
- 2026-08-29 908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates 908 Devices NASDAQ: MASS outlined its strategy to expand in handheld chemical detection following second-quarter 2026 results that showed revenue growth, a narrower adjusted EBITDA loss and increasing recurring revenue.